Bibliographic Info
GuidelineWHO consolidated guidelines on tuberculosis: module 3: diagnosis
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
High
In people with bacteriologically confirmed rifampicin-resistant pulmonary TB disease, targeted next generation sequencing technologies may be used on respiratory samples to diagnose resistance to isoniazid, fluoroquinolones and pyrazinamide rather than culture-based phenotypic drug susceptibility testing.
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 3rd ed.
Year2024
InstitutionWorld Health Organization